A new study by University of Arizona Health Sciences researchers found that an immunotherapy previously shown to be ineffective against prostate cancer may have therapeutic potential when combined ...

The study, published in Briefings in Bioinformatics on February 20, highlights iDOMO's ability to identify synergistic drug combinations using gene expression data, outperforming existing methods.

The study highlights iDOMO's ability to identify synergistic drug combinations using gene expression data, outperforming existing methods. Researchers at the Icahn School of Medicine at Mount ...

Meanwhile, MIDF Research said the proposed acquisition of the NSL stake is expected to create synergistic benefits to the YTL group while opening doors to new markets for the company.